STOCK COMMENTS / EPS CHANGESAllergan ( AGN) price target increased at Citigroup to $124, Citigroup said. Core franchises continue to deliver double digit growth. Buy rating. Akamai Tech ( AKAM) target lowered at Jefferies. Shares of AKAM now seen reaching $48, Oppenheimer said. Weak quarterly report. Outperform rating. Biogen Idec ( BIIB) numbers raised at Jefferies. Shares of BIIB now seen reaching $210, Jefferies said. Estimates also raised on acquisition of Tysabri rights. Buy rating. Cummins ( CMI) target raised at UBS to $135, UBS said. Opportunity to rally as investors were braced for cautious guidance. Cummins target lowered at Jefferies to $110, Jefferies said. Solid quarter and guidance. Hold rating. CVS Caremark ( CVS) numbers increased at Guggenheim. CVS estimates were raised through 2014, Guggenheim said. Company boosted its guidance. Buy rating and new $60 price target. Green Mountain ( GMCR) numbers boosted at Lazard. Shares of GMCR now seen reaching $58, according to Lazard Capital Markets. Estimates also upped, given a better margin outlook. W.R. Grace ( GRA) numbers raised at Jefferies. Shares of GRA now seen reaching $90, Jefferies said. Estimates also raised on solid earnings momentum. Buy rating. InterActiveCorp ( IACI) estimates, target cut at Credit Suisse. Shares of IACI now seen reaching $62, according to Credit Suisse. Estimates also reduced, given a deceleration of search growth. Outperform rating. Panera Bread ( PNRA) target raised at Jefferies to $190, Jefferies said. Trends are quite steady vs peers. Buy rating. Ralph Lauren ( RL) numbers raised at UBS. Shares of RL now seen reaching $195, UBS said. Estimates also increased on an accelerating top line story. Buy rating. Ralph Lauren numbers raised at Credit Suisse. Shares of RL now seen reaching $198, according to Credit Suisse. Estimates also increased, given higher international growth and margin expansion. Outperform rating. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.